Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BUFFALO, NY--(Marketwired - Apr 29, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on May 8, 2014, it will report its financial results for the first quarter ended March 31,...
-
BUFFALO, NY--(Marketwired - Apr 16, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the achievement of all objectives in a Phase 1 clinical trial of CBL0102, or quinacrine, an orally...
-
BUFFALO, NY--(Marketwired - Apr 1, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced two upcoming poster presentations at the 2014 American Association for Cancer Research (AACR) Annual...
-
BUFFALO, NY--(Marketwired - Mar 11, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the fourth quarter and fiscal year ended December 31,...
-
BUFFALO, NY--(Marketwired - Feb 27, 2014) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on March 11, 2014, it will report its financial results for the fourth quarter and...
-
BUFFALO, N.Y., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Company is scheduled to present at the 2014 BIO CEO & Investor Conference, February...
-
BUFFALO, N.Y., Jan. 23, 2014 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Biomedical Advanced Research and Development Authority ("BARDA") has terminated...
-
BUFFALO, N.Y., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that it has entered into definitive agreements with two institutional investors to purchase an...
-
BUFFALO, N.Y., Dec. 18, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported that Chief Development Officer, Jean Viallet, MD will leave the Company to assume an oncology...
-
BUFFALO, N.Y., Dec. 3, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Company is scheduled to present at the Oppenheimer & Co. 24th Annual Healthcare...